ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers

April 27, 2007

Northwestern’s Warren Kibbe Named Director of NCI CBIIT

June 26, 2013

NCI Workshop Not “A Formality,” Baines Responds To Kopans

November 19, 1993

Gene Patterns Predict Lymphoma Response To Treatment

June 28, 2002

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

Duke Scores Highest On NCAB Review

July 14, 1978